Novavax, Inc. (NVAX) Latest Stock News & Headlines - Yahoo …
Jul 1, 2022 · Get the latest Novavax, Inc. (NVAX) stock news and headlines to help you in your trading and investing decisions.
Novavax Inc (NVAX) Q3 2024 Earnings Call Highlights: Strategic ...
1 day ago · In This Article: Total Revenue: $85 million for Q3 2024. Product Sales: $38 million for Q3 2024, compared to $2 million in Q3 2023. Cost of Sales: $61 million for Q3 2024, compared to $99 million ...
Novavax Third Quarter 2024 Earnings: Beats Expectations
10 hours ago · Novavax (NASDAQ:NVAX) Third Quarter 2024 Results. Key Financial Results. Revenue: US$84.5m (down 55% from 3Q 2023). Net loss: US$121.3m (loss narrowed by 7.2% from 3Q 2023). US$0.76 loss per share ...
Novavax: Balancing Potential and Risk Amid Strategic Shifts and ...
1 day ago · Novavax (NVAX) Company Description: Novavax, Inc. is a late-stage biotechnology company, which focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases.
Novavax climbs as FDA lifts clinical hold on Covid, flu combo trials
1d. N ovavax (NASDAQ: NVAX) shares climbed 12% premarket on Monday after the U.S. FDA lifted clinical hold on the investigational new drug application for the pharma firm’s COVID-19-Influenza ...
Novavax's Updated Protein-based COVID-19 Vaccine Now an …
Nov 28, 2023 · Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that Nuvaxovid™ XBB.1.5 COVID-19 Vaccine (NVX-CoV2601) has been...
Novavax’s stock slides 7% as guidance cut offsets narrower-than ...
2 days ago · Novavax Inc.’s stock fell 4% Tuesday after the company cut its full-year guidance, offsetting a narrower-than-expected third-quarter loss and better-than-expected revenue.
Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML …
21 hours ago · As the third-quarter earnings season ends this week, the focus in the biotech sector is mostly on pipeline and key regulatory updates. Novavax (NVAX Quick Quote NVAX - Free Report) was in focus ...
Novavax Q3 Earnings & Sales Beat, Stock Falls 6% on '24 View Cut
1 day ago · More on NVAX’s Earnings. Novavax recorded $38.2 million in product sales compared with $2.2 million in the year-ago quarter. This upside was primarily driven by sales of the company’s protein ...
Novavax shares soar on license deal with Sanofi at lofty valuation
May 10 (Reuters) - Novavax (NVAX.O) on Friday said it had struck a licensing deal worth at least $1.2 billion with Sanofi (SASY.PA) for its COVID-19 vaccine in exchange for a stake that valued...